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Several diarylamines in the benzo[b]thiophene series were
prepared in good to high yields by palladium-catalysed am-
ination of ethyl 3-bromobenzo[b]thiophene-2-carboxylate
with anilines and 5-aminoindole in the presence of Pd(OAc)2,
BINAP and Cs2CO3 in toluene. The presence of the ester
group at the 2-position of the benzo[b]thiophene moiety in-
creases the yields and lowers the heating times relative to the
reactions performed with 3-bromobenzo[b]thiophene. When
aminopyridines were used instead of anilines, the ligand and
the solvent need to be changed to XANTHPHOS and diox-
ane in the amination reaction. With 2-aminopyridine a one-
pot C−N coupling and intramolecular cyclization involving
the nitrogen atom of the pyridine ring occurred, with loss of
Introduction
Benzo[b]thiophenes are important heterocycles, either as
biologically active molecules or as luminescent components
used in organic materials.[1] One of the most important
drugs based on the benzo[b]thiophene system is Raloxifene,
approved by the U. S. Food and Drug Administration for
the prevention and treatment of osteoporosis in postmeno-
pausal women.[2] Extensive research into other potential ap-
plications of this drug, namely for the treatment of Alzhei-
mer’s disease, is currently in progress.[3] In the same series, a
number of 3-[(4-pyridinyl)amino]benzo[b]thiophenes, which
are selective serotonin re-uptake inhibitors, have been pre-
pared and may be useful in the treatment of central nervous
system disorders, including obsessive compulsive dis-
orders.[4]
[a] Departamento de Quı´mica, Universidade do Minho,
Campus de Gualtar, 4710-057 Braga, Portugal
Fax: (internat.)  351-253678983
E-mail: mjrpq@quimica.uminho.pt
[b] Laboratoire d’Inge´nierie Mole´culaire et Biochimie
Pharmacologique, Faculte´ des Sciences, Universite´ de Metz
1, bd Arago Metz Technopole, 57078 Metz Cedex 3, France
[c] Escola Superior Agra´ria, Instituto Polite´cnico de Braganc¸a
Campus de Sta Apolo´nia, 5300 Braganc¸a, Portugal
Eur. J. Org. Chem. 2004, 36793685 DOI: 10.1002/ejoc.200400218  2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 3679
ethanol, giving an interesting fluorescent tetracyclic het-
eroaromatic compound. The antimicrobial activity, the min-
imal inhibitory concentrations (MICs) and the structure-ac-
tivity relationships (SARs) were evaluated. A selectivity with
low MICs was observed against Bacillus Cereus, and good
results were also obtained against Candida albicans. The ac-
ids obtained by hydrolysis of the ester group, as non-pro-
teinogenic α,β-unsaturated β-amino acids, can be incorpor-
ated into peptide chains to induce conformational con-
straints.
( Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
Germany, 2004)
We have recently become interested in palladium-cata-
lysed arylamination of benzo[b]thiophenes, either in the
benzene or in the thiophene ring, to obtain the correspond-
ing diarylamines and in some cases tetracyclic aromatic
compounds resulting from intramolecular cyclizations.[5]
We have been able to establish that under the same CN
coupling[6] conditions [Pd(OAc)2 (3mol %), Cs2CO3 (1.4
equiv.) and BINAP (4mol %) in toluene] it was possible to
obtain either primary amines[5b] or diarylamines[5b,5c] in the
benzene ring of the benzo[b]thiophene moiety. The same
conditions were ineffective for the amination of 3-bromo-
benzo[b]thiophene with ortho-bromoanilines, for which
tBuONa and larger amounts of Pd(OAc)2 and BINAP were
required.[5c] In this work we extend the scope of the former
conditions to the coupling of ethyl 3-bromobenzo[b]thio-
phene-2-carboxylate (1a) (electron-deficient) and 3-bromo-
benzo[b]thiophene (1b) (relatively electron-rich) with aro-
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matic amines. Other conditions were required for the coup-
ling with aminopyridines, as already described by other au-
thors for heteroaromatic amines.[7] The antimicrobial
activities and minimal inhibitory concentrations (MICs) of
some of the prepared compounds against bacteria and
against Candida albicans were evaluated, together with
structure-activity relationships (SARs). The acids obtained
by hydrolysis of the ester group, as non-proteinogenic α,β-
unsaturated β-amino acids, can be incorporated into pep-
tides to induce conformational constraints, which can help
in the study of the structure of proteins.
Results and Discussion
The precursor ethyl 3-bromobenzo[b]thiophene-2-car-
boxylate (1a) was prepared from the corresponding 3-am-
ino compound by treatment with tBuONO and CuBr2.[8]
The 3-amino compound was in turn synthesized by treat-




Compound 1a was coupled with several anilines and with
5-aminoindole under the same conditions to give diarylam-
ines 2 in good to high yields (Scheme 2). When 5-aminoin-
dole was used as coupling component, the yield of the cou-
pled product after 5 h of heating was only 40%, while on
leaving the reaction overnight the yield was increased to
63%. In order to compare yields, two reactions with 3-
bromobenzo[b]thiophene (1b) were performed. The pres-
ence of the ester group in the 2-position increases the reac-
tion yields and lowers the heating times (Scheme 2).
Under the same conditions, 2- and 3-aminopyridines did
not react. Changing the conditions to those used by other
authors for the coupling of heteroaromatic amines[7] af-
forded the interesting tetracyclic compound 4 from 2-amino-
pyridine and the diarylamine 5 from 3-aminopyridine
(Scheme 3). The former compound was the result of a CN
coupling followed by an intramolecular cyclization involv-
ing the nitrogen atom of the pyridine ring, with loss of etha-
nol. For the synthesis of compound 5 in good yield more
time and greater quantities of Pd were needed, Pd(OAc)2
also being effective as Pd source.
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Scheme 2. (i) Pd(OAc)2 (3 mol%), BINAP (4 mol%), Cs2CO3 (1.4
equiv.), toluene, 100 °C, Ar; (ii) 1. 30% NaOH, EtOH, ∆, 2. HCl
(1)
Scheme 3. i) Pd2dba3 (3 mol% Pd), XANTPHOS (4 mol%),
Cs2CO3 (1.4 equiv.), dioxane, 100 °C, Ar; [a] Pd(OAc)2 (6 mol%)
Compound 4, as a planar compound, can intercalate into
the DNA bases, acting as an anti-tumour compound and/
or as a biomarker, thanks to its fluorescence (Figure 1). It
showed a λem(max.)  435 nm and a relative quantum yield
of fluorescence in dichloromethane of Φdcm  0.13, deter-
mined by the standard method[11] with 9,10-diphenylan-
thracene in ethanol as reference (ΦEtOH  0.95),[12] at
λexc.  368 nm and with application of Equation (1) [A 
absorbance at the excitation wavelength of the solutions in
dichloromethane (s) and EtOH (r); F  integrated emission
area; n  refraction index of the solvents used; subscripts
refer to the reference (r) or sample (s) compound].
(1)
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Figure 1. Fluorescence spectrum of compound 4 in dichlorometh-
ane (106 ) (λexc.  368 nm) showing a λem  435 nm
This excitation wavelength (λexc.) was chosen from the
absorption spectrum of compound 4 (see Exp. Sect.) after
verification that when λexc.  387 nm was used the com-
pound was already emitting at lower wavelengths. The diar-
ylamine 5 showed only a residual fluorescence (λexc. 
362 nm) with a λem(max.)  431 nm and a negligible quan-
tum yield of fluorescence in dichloromethane (Φdcm 
0.0008) relative to the same reference compound in ethanol.
Hydrolysis of the Ester Group
The corresponding acids 6a and 6b were obtained in al-
most quantitative yield by hydrolysis of the diarylamines 2a
and 2b with NaOH in EtOH/H2O and subsequent acidifi-
cation with HCl (Scheme 2). The β-amino acids α,β-unsatu-
rated 6a and 6b thus obtained can be inserted into peptides
to induce conformational constraints, which can help in the
study of the structure of proteins.
Attempted Cyclization of the Acids and Esters
The acid 6a was subjected to unsuccessful attempts at
cyclization with PPA and acidic Al2O3 in order to obtain
the corresponding acridinones. The acids are highly polar
and did not dissolve in PPA even when it was preheated.
When compound 6b was melted prior to addition, decar-
boxylation to compound 3a occurred quantitatively with
the heat. With use of acidic Al2O3, which some of us have
used as an acid catalyst and water retainer in chromeniz-
ation reactions,[10] in dioxane at 110 °C overnight, decar-
boxylation from 6a to 7 took place (Scheme 4). When the
reaction was performed at 60 °C for 3 d, starting material
and small amounts of compound 7 (formed as time passed)
were isolated.
Scheme 4
The ester 2a was subjected to the FriedelCrafts con-
ditions described for the synthesis of cyclic constrained ana-
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logues of Raloxifene, resulting from diaryl compounds in-
volving the 4-position of the benzo[b]thiophene moiety and
possessing an ester group in the 3-position,[3] but in our
case only demethylation to the hydroxy compound 8 oc-
curred (Scheme 5). The same conditions were applied to the
fluoro compound 2c, but no reaction took place.
Scheme 5
It seems that the diarylamine moiety does not provide
suitable activation for the methods examined with the ester
compounds. The easy decarboxylation with the temperature
is also a problem for the cyclization of the corresponding
acids.
In Vitro Antimicrobial Activity and SAR
A screening of antibacterial activities with two Gram-
negative (Escherichia coli CECT 101 and Pseudomonas
aeruginosa CECT 108) and two Gram-positive bacteria
(Bacillus subtilis CECT 498 and Bacillus cereus CECT 148)
was performed; antifungal activity against Candida albicans
(CECT 1394) was assessed for some of the compounds ob-
tained, and the minimal inhibitory concentrations (MICs in
µg/mL) were determined (Table 1) by an adaptation of the
agar streak dilution method based on radial diffusion.[13]
Table 1. Antimicrobial activities of some of the synthesized com-
pounds (CECT-Spanish type culture collection of Valencia Univer-
sity)
Compounds MIC in µg/mL (zone of inhibition in mm)
Bacillus cereus Candida albicans
CECT 148 CECT 1394
2a 3.13 (14) 100 (8)
8 3.13 (10) 100 (8)
2b 3.13 (11) 100 (5)
6b 3.13 (7) 50 (7)
2c 3.13 (12) 200 (7)
3b 3.13 (14) 50 (8)
4 1.56 (10) 12.5 (10)
5 1.56 (8) 12.5 (8)
Ampicillin 3.13 (13) 
Chloramphenicol 3.13 (8) 
Cyclohexamide  12.5 (5)
Suspensions of the microorganism containing approxi-
mately 108 cfu/mL were prepared, and the plates were in-
oculated. A stock solution of the synthesized compound
(1000 µg/mL) in DMSO was prepared, and graded dilutions
of the tested compounds were incorporated in cavities
M.-J. R. P. Queiroz et al.FULL PAPER
(depth 3 mm, diameter 4 mm) made in the centres of the
petri dishes (nutrient agar for antibacterial activity and sa-
bouraud dextrose agar medium for antifungal activity). The
plates were incubated in duplicate at 37 °C (for bacteria)
and at 30 °C (for fungi) for 24 h. Under the same con-
ditions, different concentrated solutions of ampicillin, chlo-
ramphenicol (antibacterial) and cyclohexamide (antifungal)
in DMSO were used as standards. The MIC was considered
to be the lowest concentration of the tested compound to
inhibit growth of bacteria or fungi on the plate. The diam-
eters of the inhibition zones corresponding to the MICs
are presented in Table 1. Positive control with use only of
inoculation and negative control with use only of DMSO
in the cavity were also carried out.
The compounds tested were not active against the Gram-
negative bacteria or Bacillus subtilis but only against Bacil-
lus cereus. Table 1 shows the MICs for B. cereus and C.
albicans as an evaluation of the antimicrobial activity of the
tested compounds.
From inspection of Table 1 it can be concluded that all
the compounds exhibit low MICs for B. cereus and that
compounds 4 and 5, containing the pyridine ring, show the
lowest MICs (1.56 µg/mL), even lower than the MICs for
the antibacterial compounds. For the same compounds the
lowest MICs (12.5 µg/mL) were also observed against C.
albicans and are similar to that of cyclohexamide. The pres-
ence of the acid group in compound 6b lowers the MIC
against C. albicans from 100 to 50 µg/mL in comparison
with compound 2b. Compound 2c shows the highest MIC
against C. albicans (200 µg/mL) but without the ester group
the corresponding fluoro compound 3b has a much more
lower MIC (50 µg/mL).
Conclusions
Several diarylamines were prepared from electron-de-
ficient or relatively electron-rich bromobenzo[b]thiophenes
and aromatic amines under the same CN coupling con-
ditions. The use of XANTHPHOS as ligand was needed for
coupling of ethyl 3-bromobenzo[b]thiophene-2-carboxylate
with aminopyridines. A tetracyclic heteroaromatic fluor-
escent compound was obtained from the coupling of 2-
aminopyridine by a one-pot CN coupling and intra-
molecular cyclization with loss of ethanol.
Attempts to cyclize the esters and acids to acridinones
have so far been unsuccessful.
In vitro antimicrobial activity, MICs and SARs were
evaluated. Selectivity against B. cereus was observed, with
low MICs. Good results against C. albicans were also ob-
tained, especially for the compounds possessing a pyridine
ring.
Experimental Section
General Remarks: Melting points were determined with a Gallenk-
amp apparatus and are uncorrected. The 1H NMR spectra were
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measured with a Varian Unity Plus instrument at 300 MHz. Spin-
spin decoupling techniques were used to assign the signals. The 13C
NMR spectra were measured with the same instrument at
75.4 MHz (using DEPT, θ  45°). The IR spectra were recorded
as Nujol mulls with a PerkinElmer 1600-FTIR spectrophoto-
meter. The UV spectra were recorded with a Shimadzu UV-250
1PC, UV/Vis recording spectrophotometer. Elemental analyses
were determined with a LECO CHNS 932 elemental analyser.
Mass spectra (EI) and HRMS data were recorded by the mass spec-
trometry service of University of Vigo, Spain, or with a Micromass
Autospec 3F. The fluorescence studies were performed with a Spex
Fluorolog 1680 Double Spectrometer spectrofluorimeter. Column
chromatography was performed with MachereyNagel silica gel
(230400 mesh). ‘‘Petroleum ether’’ refers to the fraction with boil-
ing range 4060 °C. ‘‘Ether’’ refers to diethyl ether. When a solvent
gradient was used the increase in the polarity was carried out
gradually from neat petroleum ether to mixtures of ether/petroleum
ether, increasing by 10% of ether until the isolation of the product.
Ethyl 3-Bromobenzo[b]thiophene-2 carboxylate (1a): Compound 1a
was obtained according to literature methods[8,9] in 60% overall
yield as an orange solid, m.p. 6062 °C. IR: ν˜max.  1725 (CO)
cm1. 1H NMR (CDCl3): δ  1.45 (t, J  7 Hz, 3 H,
CO2CH2CH3), 4.45 (q, J  7 Hz, 2 H, CO2CH2CH3), 7.497.58
(m, 2 H, ArH), 7.807.86 (m, 1 H, ArH), 7.978.02 (m, 1 H, ArH)
ppm. 13C NMR (CDCl3): δ  14.18 (CH3), 61.77 (CH2), 114.70
(C), 122.53 (CH), 125.17 (CH), 125. 50 (CH), 127.99 (CH), 138.53
(C), 139.17 (C), 161.34 (CO) ppm. C11H9BrO2S (285.16): calcd.
C 46.33, H 3.18, S 11.24; found C 46.69, H 3.56, S 11.48.
General Procedure for CN Cross Coupling with Anilines and 5-
Aminoindole: A dry Schlenk tube was charged under Ar with dry
toluene (35 mL), compound 1a or 1b, Pd(OAc)2 (3 mol %), racBI-
NAP (4 mol %), Cs2CO3 (1.4 equiv.) and, finally, the amine. The
reaction mixture was stirred and heated at 100 °C for several hours
(Scheme 2). After the mixture had cooled, water and ether were
added, and the phases were separated. The aqueous phase was ex-
tracted with more ether, and the organic phases were collected,
dried (MgSO4) and filtered, and removal of the solvent gave an oil,
after addition of MeOH to remove traces of toluene. The oil was
subjected to column chromatography.
Ethyl 3-[(4-Methoxyphenyl)amino]benzo[b]thiophene-2-carboxylate
(2a): This compound was produced from compound 1a (300 mg,
1.05 mmol) and p-anisidine (130 mg, 1.05 mmol) and was purified
by column chromatography with use of a solvent gradient from
neat petroleum ether to 10% ether/petroleum ether. Product 2a
(263 mg, 76%) was obtained as an orange solid. Recrystallization
from ether/petroleum ether gave yellow crystals, m.p. 8789 °C.
IR: ν˜max.  3305 (NH), 1667 (CO) cm1. 1H NMR (CDCl3): δ 
1.42 (t, J  7 Hz, 3 H, CO2CH2CH3), 3.83 (s, 3 H, OCH3), 4.38
(q, J  7 Hz, 2 H, CO2CH2CH3), 6.86 (d, J  8.7 Hz, 2 H, 2 
ArH), 7.067.11 (m, 3 H, ArH), 7.22 (d, J  8 Hz, 1 H, ArH),
7.357.40 (m, 1 H, Ar-H), 7.73 (d, J  8 Hz, 1 H, ArH), 8.81 (s,
1 H, NH) ppm. 13C NMR (CDCl3): δ  14.44 (CH3), 55.46
(OCH3), 60.69 (CH2), 103.77 (C), 114.22 (2  CH), 123.15 (CH),
123.18 (CH), 124.90 (2  CH), 125.59 (CH), 127.45 (CH), 131.58
(C), 135.01 (C), 140.23 (C), 147.60 (C), 156.69 (C), 165.74 (CO)
ppm. C18H17NO3S (327.40): calcd. C 66.04, H 5.23, N 4.28, S 9.79;
found C 66.00, H 5.43, N 4.48, S 9.79.
Ethyl 3-[(2,4-Dimethoxyphenyl)amino]benzo[b]thiophene-2-car-
boxylate (2b): This compound was produced from compound 1a
(300 mg, 1.05 mmol) and 2,4-dimethoxyaniline (161 mg,
1.05 mmol) and was purified by column chromatography with use
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of a solvent gradient from neat petroleum ether to 20% ether/petro-
leum ether. Product 2b (300 mg, 80%) was obtained as an orange
solid. Recrystallization from ether/petroleum ether gave yellow
crystals, m.p. 9596 °C. IR: ν˜max.  3319 (NH), 1666 (CO) cm1.
1H NMR (CDCl3): δ  1.42 (t, J  7 Hz, 3 H, CO2CH2CH3), 3.83
(s, 3 H, OCH3), 3.85 (s, 3 H, OCH3), 4.38 (q, J  7 Hz, 2 H,
CO2CH2CH3), 6.37 (dd, J  8.7, 2.7 Hz, 1 H, 5-H), 6.56 (d, J 
2.7 Hz, 1 H, 3-H), 6.93 (d, J  8.7 Hz, 1 H, 6-H), 7.087.14 (m,
1 H, ArH), 7.347.41 (m, 2 H, ArH), 7.72 (d, J  8 Hz, 1 H,
ArH), 8.58 (s, 1 H, NH) ppm. 13C NMR (CDCl3): δ  14.45 (CH3),
55.55 (OCH3), 55.69 (OCH3), 60.66 (CH2), 99.21 (CH), 103.41
(CH) 104.34 (C), 123.12 (CH), 123.16 (CH), 123.17 (CH), 124.30
(C), 125.35 (CH), 127.40 (CH), 131.91 (C), 140.06 (C), 147.08 (C),
153.19 (C), 157.16 (C), 165.55 (CO) ppm. C19H19NO4S (357.42):
calcd. C 63.85, H 5.36, N 3.92, S 8.97; found C 63.68, H 5.49, N
4.04, S 8.96.
Ethyl 3-[(4-Fluorophenyl)amino]benzo[b]thiophene-2-carboxylate
(2c): This compound was produced from compound 1a (150 mg,
0.526 mmol) and 4-fluoroaniline (64.0 mg, 0.526 mmol) and was
purified by column chromatography with use of a solvent gradient
from neat petroleum ether to 20% ether/petroleum ether. Product
2c (105 mg, 63%) was obtained as a yellow solid. Recrystallization
from ether/petroleum ether gave light yellow crystals, m.p. 119121
°C. IR: ν˜max.  3294 (NH), 1668 (CO) cm1. 1H NMR (CDCl3):
δ  1.42 (t, J  7 Hz, 3 H, CO2CH2CH3), 4.39 (q, J  7 Hz, 2 H,
CO2CH2CH3), 6.977.17 (m, 5 H, ArH), 7.257.29 (m, 1 H,
ArH), 7.387.44 (m, 1 H, ArH), 7.76 (d, J  8 Hz, 1 H, ArH),
8.75 (s, 1 H, NH) ppm. 13C NMR (CDCl3): δ  14.40 (CH3), 60.90
(CH2), 106.19 (C) 115.73 (d, J  22.7 Hz, CH-3 and -5), 123.27
(CH), 123.39 (CH), 123.80 (d, J  8 Hz, CH-2 and -6), 125.37
(CH), 127.57 (CH), 131.60 (C), 138.27 (d, J  2.8 Hz, C-1), 140.09
(C), 146.41 (C), 159.45 (d, J  242.7 Hz, CF), 165.55 (CO) ppm.
C17H14FNO2S (315.36): calcd. C 64.75, H 4.47, N 4.44, S 10.17;
found C 64.40, H 4.77, N 4.37, S 10.36.
Ethyl 3-[(Indol-5-yl)amino]benzo[b]thiophene-2-carboxylate (2d):
This compound was produced from compound 1a (250 mg,
0.877 mmol) and 5-aminoindole (116 mg, 0.877 mmol), with heat-
ing for 21 h, and was purified by column chromatography with use
of a solvent gradient from neat petroleum ether to 50% ether/petro-
leum ether. Product 2d (155 mg, 63%) was obtained as an orange
solid. Recrystallization from ether/petroleum ether gave yellow
crystals, m.p. 166168 °C. IR: ν˜max.  3382 (NH), 3307 (NH),
1631 (CO) cm1. 1H NMR (CDCl3): δ  1.43 (t, J  7 Hz, 3 H,
CO2CH2CH3), 4.39 (q, J  7 Hz, 2 H, CO2CH2CH3), 6.496.51
(m, 1 H, ArH), 6.957.00 (m, 1 H, ArH), 7.07 (dd, J  8.4, 2.1 Hz,
1 H, 6-H), 7.14 (d, J  8 Hz, 1 H, ArH) 7.257.27 (m, 1 H, ArH),
7.307.34 (m, 2 H, ArH), 7.46 (d, J  2.1 Hz, 1 H, 4-H), 7.72 (d,
J  8 Hz, 1 H, ArH), 8.20 (s, 1 H, indole NH) 9.01 (s, 1 H, NH)
ppm. 13C NMR (CDCl3): δ  14.48 (CH3), 60.59 (CH2), 102.56
(C) 102.72 (CH), 111.30 (CH) 115.90 (CH), 119.91 (CH) 123.03
(CH), 123.04 (CH), 125.17 (CH), 125.91 (CH), 127.39 (CH), 128.17
(C), 131.79 (C), 133.58 (C), 134.49 (C) 140.32 (C), 148.52 (C),
165.89 (CO) ppm. C19H16N2O2S (336.41): calcd. C 67.84, H 4.79,
N 8.33, S 9.53; found C 67.56, H 4.90, N 8.29, S 9.32.
3-[(2,4-Dimethoxyphenyl)amino]benzo[b]thiophene (3a): This com-
pound was produced from compound 1b (249 mg, 1.17 mmol) and
2,4-dimethoxyaniline (180 mg, 1.17 mmol) and was purified by col-
umn chromatography with use of a solvent gradient from neat
petroleum ether to 10% ether/petroleum ether. Product 3a (200 mg,
60%) was obtained as an oil. 1H NMR (CDCl3): δ  3.83 (s, 3 H,
OCH3), 3.94 (s, 3 H, OCH3), 6.10 (s, 1 H, NH), 6.50 (dd, J  8.7,
2.7 Hz, 1 H, 5-H), 6.64 (d, J  2.7 Hz, 1 H, 3-H), 6.90 (s, 1 H,
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2-H), 7.22 (d, J  8.7 Hz, 1 H, 6-H), 7.417.44 (m, 2 H, 7- and
4-H), 7.767.80 (m, 1 H, ArH), 7.867.90 (m, 1 H, ArH) ppm.
13C NMR (CDCl3): δ  55.53 (OCH3), 55.56 (OCH3), 99.24 (CH),
103.74 (CH) 104.11 (C), 116.08 (CH), 120.19 (CH), 123.01 (CH),
123.61 (CH), 124.67 (CH), 127.40 (C), 134.27 (C), 136.08 (C),
138.73 (C), 149.09 (C), 153.96 (C) ppm. MS: m/z (%)  287 (7)
[M  2], 286 (20) [M  1], 285 (100) [M], 270 (51) [M 
15], 138 (19). HRMS: calcd. for C16H13NO2S [M] 285.082298,
found 285.082351.
3-[(4-Fluorophenyl)amino]benzo[b]thiophene (3b): This compound
was produced from compound 1b (300 mg, 1.41 mmol) and 4-
fluoroaniline (156 mg, 1.41 mmol) and was purified by column
chromatography with use of a solvent gradient from neat petroleum
ether to 10% ether/petroleum ether. Product 3b (127 mg, 40%) was
obtained as a white solid. Recrystallization from ether/petroleum
ether gave colourless crystals, m.p. 8789 °C. IR: ν˜max.  3388
(NH) cm1. 1H NMR (CDCl3): δ  5.68 (s, 1 H, NH), 6.91 (s, 1
H, 2-H), 6.98 (s, 4 H, 2-, 3-, 5- and 6-H), 7.387.41 (m, 2 H,
ArH), 7.647.67 (m, 1 H, ArH), 7.837.86 (m, 1 H, ArH) ppm.
13C NMR (CDCl3): δ  107.83 (CH), 115.90 (d, J  22.5 Hz, CH-
3 and -5), 118.05 (d, J  8 Hz, CH-2 and -6), 120.41 (CH),
123.25 (CH), 123.91 (CH), 124.92 (CH), 134.20 (C), 135.77 (C)
138.97 (C), 140.64 (C), 157.37 (d, J  238.7 Hz, CF) ppm.
C17H10FNS (243.30): calcd. C 69.11, H 4.14, N 5.76, S 13.18; found
C 69.00, H 4.35, N 5.76, S 13.05.
General Procedure for CN Cross Coupling with Aminopyridines:
A dry Schlenk tube was charged under Ar with dry 1,4-dioxane
(35 mL), compound 1a, [Pd2dba3] (3 mol %Pd) or Pd(OAc)2 (6
mol %), XANTHOPS (4 mol %), Cs2CO3 (1.4 equiv.) and, finally,
the aminopyridine (1.1 equiv.). The reaction mixture was stirred
and heated at 100 °C for several hours (Scheme 3). After it had
cooled, water and ether were added and the phases were separated.
The aqueous phase was extracted with more ether, the organic
phases were collected, dried (MgSO4) and filtered, and removal of
solvent gave an oil or a solid. The oil was subjected to column chro-
matography.
6H-Benzo[b]thieno[3,2-d]pyrido[1,2-a]pyrimidin-6-one (4): This com-
pound was produced from compound 1a (200 mg, 0.702 mmol) and
2-aminopyridine (73.0 mg, 0.772 mmol) and was obtained as a be-
ige solid (100 mg, 60%). Recrystallization from ether gave light be-
ige crystals, m.p. 211213 °C. IR: ν˜max.  1693 (CO) cm1. UV
(CH2Cl2): λmax. (ε, dm3·mol1·cm1)  387 (6066), 368 (7238), 303
(2062), 276 (14842), 257 (18772) nm. 1H NMR ([D6]DMSO): δ 
7.317.38 (m, 1 H, ArH), 7.58765 (m, 1 H, ArH), 7.697.76 (m,
1 H, ArH) 7.817.93 (m, 2 H, ArH), 8.16 (d, J  8 Hz, 1 H, ArH),
8.37 (br. d, J  8 Hz, 1 H, ArH) 9.01 (br. d, J  8 Hz, 1 H, ArH)
ppm. 13C NMR ([D6]DMSO): δ  113.21 (C), 115.46 (CH), 123.80
(CH), 124.01 (CH), 125.52 (CH), 125.91 (CH), 126.32 (CH), 130.06
(CH), 133.93 (C), 135.98 (CH), 141.23 (C), 149.28 (C), 153.38 (C),
154.05 (C) ppm. MS (EI): m/z (%)  252 (100) [M], 224 (35) [M
 CO]. HRMS: calcd. for C15H11N2OS [M] 252.035735, found
252.035591.
Ethyl 3-(3-Aminopyridine)benzo[b]thiophene-2-carboxylate (5): This
compound was produced from compound 1a (200 mg, 0.702 mmol)
and 3-aminopyridine (73.0 mg, 0.772 mmol) and was purified by
column chromatography with use of a solvent gradient from neat
petroleum ether to neat ether. Product 5 (127 mg, 40%) was ob-
tained as an orange solid. Recrystallization from ether/petroleum
ether gave light yellow crystals, m.p. 112114 °C. IR: ν˜max.  3293
(NH), 1661 (CO) cm1. UV (CH2Cl2): λmax. (ε, dm3·mol1·cm1)
362 (12099), 263 (22764) 225 (13469) nm. 1H NMR (CDCl3): δ 
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1.43 (t, J  7 Hz, 3 H, CO2CH2CH3), 4.40 (q, J  7 Hz, 2 H,
CO2CH2CH3), 7.187.24 (m, 2 H, ArH), 7.297.38 (m, 2 H,
ArH), 7.427.48 (m, 1 H, ArH), 7.79 (d, J  8.1 Hz, 1 H, ArH),
8.33 (br. d, J  4.5 Hz, 1 H, Ar-H), 8.44 (d, J  2.4 Hz, 1 H, 2-
H), 8.70 (s, 1 H, NH) ppm. 13C NMR (CDCl3): δ  14.35 (CH3),
61.17 (CH2), 109.34 (C), 123.41(2  CH), 123.83 (CH), 125.00
(CH), 127.28 (CH), 127.74 (CH), 131.59 (C), 139.01 (C), 139.87
(C), 142.79 (CH), 144.10 (CH), 144.36 (C), 165.26 (CO) ppm.
C16H14 N2O2S (298.34): calcd. C 64.41, H 4.73, N 9.39, S 10.75;
found C 64.09, H 4.95, N 9.24, S 10.70.
General Procedure for the Hydrolysis of the Ester Group: Com-
pounds 2a or 2b in ethanol (1020 mL) were treated with aqueous
NaOH solution (30%, 5 equiv.). The mixture was stirred and heated
to reflux with a water bath for some hours, the reaction being
monitored by TLC. After the mixture had cooled, the ethanol was
evaporated under reduced pressure, water was added to the ob-
tained solid, followed by HCl (1 ) until the precipitation of the
acids 6a or 6b which were obtained by filtration and drying at
50 °C.
3-[(4-Dimethoxyphenyl)amino]benzo[b]thiophene-2-carboxylic
Acid (6a): This compound was produced from compound 2a
(150 mg, 0.459 mmol), product 6a (131 mg, 96%) being obtained as
yellow solid. Recrystallization from ether gave yellow crystals, m.p.
148150 °C. IR: ν˜max.  3300 (NH), 1642 (CO) cm1. 1H NMR
(CDCl3): δ  3.85 (s, 3 H, OCH3), 6.89 (d, J  9 Hz, 2 H, 2 
ArH), 7.05 7.19 (m, 4 H, ArH), 7.40 (br. t, J  8 Hz, 1 H, ArH),
7.53 (d, J  8 Hz, 1 H, ArH), 8.84 (s, 1 H, NH) ppm. C16H13NO3S
(299.35): calcd. C 64.20, H 4.38, N 4.69, S 10.71; found C 64.03,
H 4.59, N 4.66, S 10.66.
3-[(2,4-Dimethoxyphenyl)amino]benzo[b]thiophene-2-carboxylic
Acid (6b): This compound was produced from compound 2b
(360 mg, 1.01 mmol), product 6b (328 mg, 99%) being obtained as
yellow solid. Recrystallization from ether gave yellow crystals, m.p.
152154 °C. IR: ν˜max.  3354 (NH), 1688 (CO) cm1. 1H NMR
([D6]DMSO): δ  3.76 (s, 6 H, 2  OCH3), 6.45 (dd, J  8.7 and
3 Hz, 1 H, 5-H), 6.68 (d, J  3 Hz, 1 H, 3-H), 6.89 (d, J  8.7 Hz,
1 H, 6-H), 7.137.17 (m, 2 H, ArH), 7.407.45 (m, 1 H, ArH),
7.88 (d, J  8.1 Hz, 1 H, ArH), 8.53 (s, 1 H, NH) ppm. 13C NMR
([D6]DMSO): δ  55.42 (OCH3), 55.76 (OCH3), 99.45 (CH),
103.75 (C) 104.24 (CH), 123.21(C), 123.63 (CH), 123.67(CH),
123.79 (CH), 124.42 (CH), 127.73 (CH), 131.52 (C), 139.08(C),
146.47 (C), 153.33 (C), 157.33 (C), 166.51 (CO) ppm.
C17H15NO4S (329.37): calcd. C 61.99, H 4.59, N 4.25, S 9.74; found
C 61.99, H 4.83, N 4.31, S 9.60.
Cyclization Attempts
3-[(4-Methoxyphenyl)amino]benzo[b]thiophene (7): Al2O3 (acidic
Brockman I, 10 equiv.) was added to a solution of compound 6a
(50.0 mg, 0.190 mmol) in dry CH2Cl2 (3 mL) in a Schlenk tube,
and the suspension was stirred at 110 °C under Ar overnight. After
the mixture had cooled, the alumina was removed by filtration, and
solvent removal gave product 7 (46 mg, quantitative yield) as a
solid, m.p. 102104 °C. 1H NMR (CDCl3): δ  3.81(s, 3 H,
OCH3), 5.70 (br. s, 1 H, NH), 6.76 (s, 1 H, 2-H), 6.87 (d, J  9 Hz,
2 H, 2  ArH), 7.05 (d, J  9 Hz, 2 H, 2  ArH), 7.357.42 (m,
2 H, ArH), 7.647.69 (m, 1 H, ArH), 7.817.85 (m, 1 H, ArH)
ppm. 13C NMR (CDCl3): δ  55.62 (OCH3), 104.60 (CH), 114.74
(2  CH), 119.44 (2  CH), 120.19 (CH), 123.20 (CH), 123.74
(CH), 124.79 (CH), 133.95 (C), 136.95 (C), 137.59 (C), 139.01 (C),
154.42 (C) ppm. MS (EI): m/z (%)  255 (80) [M], 240 (100) [M
 Me]. HRMS: calcd. for C15H13NOS [M] 255.0718, found
255.0726.
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Ethyl 3-[(4-Hydroxyphenyl)amino]benzo[b]thiophene-2-carboxylate
(8): A solution of BBr3 in CH2Cl2 (1 , 1.6 mmol, 1.6 mL) was
added at 0 °C to a solution of compound 2a (100 mg, 0.301 mmol)
in dry CH2Cl2 (10 mL). The solution turned green and was stirred
at 0 °C for 2 h. A saturated solution of NaHCO3 was slowly added,
and extractions were carried out with CH2Cl2. The organic phases
were collected, dried and filtered, and removal of solvent gave a
yellow green solid (95.0 mg, quantitative yield). Recrystallization
from ether/petroleum ether gave yellow green crystals, m.p.
152154 °C. IR: ν˜max.  3330 (NH), 1630 (CO) cm1. 1H NMR
(CDCl3): δ  1.41 (t, J  7 Hz, 3 H, CO2CH2CH3), 4.39 (q, J 
7 Hz, 2 H, CO2CH2CH3), 4.90 (br. s, 1 H, OH), 6.81 (d, J 8.7 Hz,
2 H, 2  ArH), 7.017.20 (m, 3 H, ArH), 7.22 (d, J  8.2 Hz, 1
H, ArH), 7.35 (br. t, J  8.2 Hz, 1 H, ArH), 7.72 (d, J  8.2 Hz,
1 H, ArH), 8.77 (s, 1 H, NH) ppm. 13C NMR (CDCl3): δ  14.47
(CH3), 60.78 (CH2), 115.83 (CH), 123.22 (4  CH), 123.25 (CH),
125.17 (CH), 125.64 (CH), 127.52 (CH), 131.63 (C), 135.24 (C),
140.32 (C), 147.56 (C), 147.57 (C) 152.71 (C), 165.84 (CO) ppm.
MS (EI): m/z (%)  313 (50) [M], 311 (90) [M  2], 267 (100),
239 (80) 210 (90). HRMS: calcd. for C17H15NO3S [M] 313.0773,
found 313.0760.
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